Alkem Laboratories announces its entry into the field of Ophthalmology with the launch of an extensive portfolio of affordable and quality eye care products.
The launch of the Ophthalmology portfolio highlights Alkem's commitment to innovation and its dedication to meeting the diverse needs of patients suffering from various eye conditions.
Blindness is a major obstacle in the lives of people. Asia has the largest number of blind people in the world. In Asia, India is home to a third of the world’s blind population. Cataract is one of the leading causes of blindness and with awareness, the number of cataract surgeries being performed per year in India is phenomenal, thereby setting a world record.
The other causes of blindness are glaucoma, uncorrected refractive errors, AMD, and diabetic retinopathy among others. Dry eye is becoming a major concern not only for the adult population, but also for the young ones due to an increased usage of digital platforms like mobiles, tablets, and computers.
In addition, Alkem Eyecare aims at enhancing the knowledge and awareness of patients by introducing a specially designed dedicated patient education website. The website has Mr. Sight - an expert meant to impart information about various eye diseases in 12 Indian languages (for the 1st time in India).
Alkem Eyecare aims to ensure that patients across India have access to quality eye care formulations at affordable prices to elevate the standard of eye care and improve the overall well-being of patients.
Alkem introduces a line-up of brands targeting key therapeutic categories for ophthalmology segment launch like dry eye and anti-infectives.